Purpose: Cervical nodal status is one of the most important denominator of prognosis in oral cavity squamous cell carcinoma. Management of clinically negative cervical node is controversial and practice varies from institution to institution. But in most of the institutions Early oral malignancy with negative neck nodes is usually managed with elective neck dissection. Sentinel node biopsy can reduce the adverse events of neck dissection. Purpose of current study is to assess outcome of the procedure in our setup. Materials and Method: This single institutional observational study was carried out in a tertiary care centre in north India Prior approval from hospital 's Scientific and Ethical committee. Total 40 Patients with early OSCC [clinical T1, T2, N0] were included over a period of 20months. Single tracer SLNB using unfiltered 99mTc-sulfur colloid were performed followed by selective neck dissection. Nodal status determined on haematoxylin and eosin testing. Data analysed at the end of study period. Results: Sentinel nodes were successfully harvested in 92.5 % cases. Average 2.4 sentinel nodes were harvested per person. In 42 % cases nodes were found in neck level II. A false negative rate of 0.11, accuracy of 0.89 and NPV of 0.86 were recorded. Highest number of false negative rate recorded in clinical stage T1 and in tongue respectively. In all three FOM cases detection of SLN failed due to shine through effect of radio colloid. Conclusion: Results showed that SLNB is technically feasible in a centre like us where sentinel lymph node biopsies are already being performed. The outcome of the procedure is comparable to the existing literature.
Introduction
Oral cavity cancer is the most common cancer in men and third most common cancer in women in India accounting for 75000 to 80000 new cases every year [1, 2] . This is because of the typical behaviour of tobacco and betel nut chewing. Prognosis largely depends upon lymph-node status and survival dropped by 50 % with involvement of neck nodes. Current practice for management of node negative disease is elective neck dissection with its attending morbidity in a significant proportion of patients who are virtually over treated [3] In the past decade, the SLN-technique has been increasingly used for other malignancies, including head and neck carcinomas. Technical developments and a gain in experience have led to a wider use of SNB, even in the complex lymphatic www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i8.87 system of the head and neck region (4, 5) . Multiple single institution studies, few multicentric trials and also some metaanalysis was done till date showing a detection rate of > 95 % and NPV of > 90 %. [6, 7] . But no direct comparison of END and SLND has been performed. Due to lack of long term follow up data and RCTs the oncological safety is not established and hence SLNB for OSCC is not a standard practice in most of the institutions. The purpose of the current study is to investigate the results of sentinel lymph node biopsy in our setup.
Aim and Objectives
Aim of this study is to investigate the reliability of sentinel lymph node biopsy in predicting the staging of neck for early oral cancer [T1-T2, N0]. Primary objective was to ascertain whether a negative hematoxylin and eosin (H& E) finding from the SLNB procedure accurately predicted the negativity of the other cervical lymph nodes (LNs) which will be represented by NPV. Secondary objective is to calculate the accuracy and false negative rate.
Methods
Total 40 patient of early oral malignancy [T1,T2 N0] with significant risk of neck metastasis were enrolled in the study after taking informed consent. Approval was obtained from Scientific and Ethics Committee of the hospital. Since all patient ultimately underwent completion ND, we sought to define a group at low, but significant, risk of developing lymphatic metastasis. Therefore, minimally invasive lesions(invasion on imaging < 4mm) and lesions smaller than 6mm in diameter were excluded from the study. Prior neck surgery, trauma, radiation, diseases which might have alter the lymphatic drainage or recent cancer history led to exclusion. Clinical staging performed by physical examination and neck imaging [CECT and CE MRI]. Patients received primary site injection with unfiltered 99Tcsulfur colloid within 18hours of the surgical procedure. Injection was performed late the day before, or on the morning of the procedure. Dosage was 300 to 400 micro curies in 5 aliquots of 0.1 mL in patients injected less than 8 hours before the procedure. Dosage was 1 mCi for patients injected the afternoon before surgery. Serial nuclear imaging was then acquired at 15 min, 30 min and 60 min. Radioactive lymph nodes were identified with handheld gamma probe (Europhobe). SLNB was done through as small an incision as possible within the planned incision for selective ND and completion ND with removal of levels I, II (including IIB), III, and IV was done subsequently. All SLNs identified using the gamma probe were removed, including any LN exhibiting10%or more of the radioactivity of the most radioactive node. Routine H&E histopathology was used at the clinical sites to evaluate the SLN(s) and non-SLN(s). The sentinel lymph nodes were fixed in 10 % neutral buffered formalin and then bisected through there long axis at 2-3 mm interval. One hematoxylin and eosin (H & E) stained slide was prepared from each block and examined for possible metastasis. The relative performance of the test was evaluated using a negative-predictive value (NPV). False Negative Rate and Accuracy for evaluation of performance of a test were also calculated. 
Results and Discussion

Discussion
There are a number of studies focusing on the use of SLN in SCC. Butonly few studies do have a homogenous clientele with only small tumours and a clinical N0 neck in which the SLN is of importance. In addition the majority of these studies did not focus on a specific region (oral cavity vs.
JMSCR Vol||06||Issue||08||Page 540-545||August 2018 oropharynx. The detection rate of sentinel lymph nodes by single dye technique in current study is 92.5 % (37/40) which compares favourably with the rate of sentinel node identification in patients undergoing SNB for head and neck cancer (8, 9) . Literature showed that there is an established role of experience of the surgeon in determining the NPV and false negative rate, which reflects the significant learning curve [10] . Sentinel lymph node biopsy is technically challenging, particularly in head and neck area and difficulties may be encountered during lymphoscintigraphy as well as during surgery; sentinel lymph node may be too close to the primary injection site to be discernible by the gamma camera, and this is particularly troublesome for sentinel nodes in submental and submandibular region (level I) for a primary tumour located in the floor of the mouth. Infact the three occasions where we are unable to retrieve the sentinel node the primary injection site was floor of mouth. It is indeed noted in some previous studies that SNB is less reliable for tumours in the floor of mouth presumably due to the close proximity of the injection site to the primary draining nodes (58). Although use of lead shields and software masking may suppress the shine -through effect of primary site in floor of mouth, some would recommend routine exploration of level I lymph node station in all cases of floor of mouth primary. Blue dye visualization may be the primary means of identifying lymph nodes in level I, with the hand-held probe being used to confirm the presence of radio colloid within the lymph node exvivo. Last, removal of the primary tumour does not remove all radioactivity from the injection site, despite adequate tumour resection margins, although the reduction in radioactivity within the primary site can aid in the subsequent identification of hot lymph nodes close to the primary tumour. Frozen section analysis was not used in this study, thus avoiding a further variable and ensuring that all the material was available for pathological analysis. The accuracy of frozen section has been questioned in melanoma and breast cancer (11, 12) . Some studies have recommended serial sectioning of the SLNs at interval of 1-mm and immunohistochemical staining for keratin with pancytokeratin to reveal occult micrometastases. A study has suggested that serial sectioning, immunohistochemistry, and molecular methods may help to identify smaller metastatic deposits. The SLN biopsy has the benefit of concentrating only on the relevant nodes for pathological examination. This selection allows a more in depth evaluation of the small number of sentinel nodes, using step serial sections and immunohistochemistry (13) . However, if there are multiple SLNs at different levels, the number of SLNs that should be removed for the examination remains unknown. The majority of studies recommend the removal of at least 2-3 SLNs to reduce the possibility of false negative results (14) . In the present study, an average of 2.3 SLNs was detected per patient. The NPV is the closest equivalent to the clinical situation in a patient with low to moderate risk of harbouring cervical metastases and represents true-negatives as a fraction of total negatives. It answers the following question: If the sentinel node is negative, what is the percentage of risk that there is occult cancer in the neck? NPV of current study is 86 % which is little inferior than the values mentioned in literature. Nonetheless the true NPV can only be determined by a trial where negative SLNBs will be observed without complete neck dissection, with several years of follow up. The false negative rate of current study is 11 % which is similar to that reported in a metaanalysis of 25,000 melanoma patients (12.5%) (38) and better than which is reported in 10-year followup of the Multicentre Selective Lymphadenectomy Trial (MSLT) inmelanoma [20 %] (15) . However, our aim is to reduce this to the 7% FNR, accepted in breast cancer which reasonably corroborating with previous literature. The identification of aberrant drainage patterns is a huge advantage which in fact giving rise to currently emerging concept of gamma probe guided neck dissection. The disadvantage of blanket ipsilateral END is illustrated in the study of pN0 necks treated by END (16) . In this series, the regional recurrence rate of 18% seems high but it is worth noting that in over one third of patients (39%) recurrence occurred in the contralateral neck. One further advantage of SNB is that because the tissues have not been significantly disturbed, comprehensive salvage surgery is possible if a recurrence is detected promptly. At the present time, SNB is not widely recognized as standard care in early oral and oropharyngeal cancer. However, increasingly it is gaining utility in Europe and in some countries, such as Denmark, it is integrated into the standard care pathway.
Conclusion
The results of our prospective study are consistent with those of previous multicentre studies, which demonstrate that sentinel lymph node biopsy technique is a valid alternative to elective neck dissection in pathological staging of early oral malignancy with the exception perhaps of floor of mouth squamous cell carcinoma. A negative sentinel node on hematoxylin and eosin study predicted the negativity of the rest of the neck with high NPV for squamous cell carcinoma of the oral cavity. Successful application of SLNB technique for oral SCC requires surgical experience and technical devices including preoperative lymphoscintigraphy and intraoperative gamma probe. More over dynamic lympho-scintigraphy would appear to show the lymphatic stream from the primary tumour and could thus allow selective neck dissection to be tailored reducing the related morbidity.
